Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-09

Clinical Trial Update: Short-course Benznidazole Treatment to Reduce Trypanosoma Cruzi Parasitic Load in Women of Reproductive Age [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a short-course benznidazole regimen to reduce Trypanosoma cruzi parasite load in women of reproductive age with Chagas disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benznidazole (benznidazole)

Snippet

Sponsor: Tulane University School of Public Health and Tropical Medicine | Conditions: Chagas Disease | Phase 3 | Status: COMPLETED | Results posted: 2026-04-09